Skip to main content

BASES ESTRUCTURALES DE LA NEUROTOXICIDAD POR ANTITUMORALES DIRIGIDOS CONTRA TUBULINA: HACIA MEJORES MODULADORES DE MICROTUBULOS CONTRA CANCER Y ENFERMEDADES NEURODEGENERATIVAS

PID2019-104545RB-I00

•
Funding agency name Agencia Estatal de Investigación
Funding agency acronym AEI
Program Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Call Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Call year 2019
State Plan 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 17
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Structural basis of noscapine activation for tubulin binding

  • Oliva, María A.
  • Prota, Andrea E.
  • Rodríguez-Salarichs, Javier
  • Wenxin, Gu
  • Bennani, Y. L.
  • Jiménez-Barbero, Jesús
  • Bargsten, Katja
  • Canales, Ángeles
  • Steinmetz, Michel O.
  • Díaz, José Fernando
Noscapine is a natural alkaloid that is used as an antitussive medicine. However, it also acts as a weak anticancer agent in certain in vivo models through a mechanism that is largely unknown. Here, we performed structural studies and show that the cytotoxic agent 7A-O-demethoxy-amino-noscapine (7A-aminonoscapine) binds to the colchicine site of tubulin. We suggest that the 7A-methoxy group of noscapine prevents binding to tubulin due to a steric clash of the compound with the T5-loop of α-tubulin. We further propose that the anticancer activity of noscapine arises from a bioactive metabolite that binds to the colchicine site of tubulin to induce mitotic arrest through a microtubule cytoskeleton-based mechanism., This work was supported by Ministerio de Ciencia e Innovación PID2019-104545RB-I00 and Fondo de Investigaciones Sanitarias COV20-01007 to JFD; CTQ2016-76263-P to AC; Swiss National Science Foundation (31003A_166608) to MOS; H2020 MSCA-ITN-2019 860070 TUBINTRAIN to AEP and JFD and a donation from Club deportivo Escuela Hungaresa de Pontevedra., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

A method for the stereoselective construction of the hemiaminal center in zampanolides

  • Brütsch, Tobias M.
  • Berardozzi, Simone
  • Rothe, Marlene L.
  • Redondo-Horcajo, Mariano
  • Díaz, José Fernando
  • Altmann, Karl-Heinz
4 p.-1 fig.-1 tab.-i graph. abst.-5 schem., We have developed a new method for the stereoselective establishment of the N-acyl hemiaminal moiety in zampanolide-type structures that involves the reaction of (Z,E)-sorbamide (3) with BINAL-H and subsequent amide transfer froma putative aluminum carboximidoate complex to the aldehyde moiety of a dactylolide precursor, such as 2 or 5. The method has enabled the efficient synthesis of 13-desmethylene-(−)-zampanolide (4), which was found to be an equipotent cell growth inhibitor as the natural product (−)-zampanolide (1)., This work was supported by the Swiss National Science Foundation (Projects 200021_149253 and 200020_175744 (KHA)). Funding was also obtained from the Ministerio de Ciencia e Innovación PID2019-104545RB-I00 and H2020-MSCA-ITN-2019 860070 TUBINTRAIN (JFD)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Synthesis of morpholine‐based analogues of (−)‐zampanolide and their biological activity

  • Bold, Christian Paul
  • Gut, Melanie
  • Schürmann, Jasmine
  • Lucena-Agell, Daniel
  • Gertsch, Jürg
  • Díaz, José Fernando
  • Altmann, Karl-Heinz
9 p.-1 fig.-1 tab.-6 schem., We describe the convergent synthesis of threeprototypical examples of a new class of analogues of thecomplex, cytotoxic marine macrolide ()-zampanolide thatincorporate an embedde d N-substituted morpholine moietyin place of the natural tetrahydropyran ring. The final con-struction of the macrolactone core was based on a high-yielding intramolecular HWE olefination, while the hemiami-nal-linked side chain was elaborated through a stereoselec-tive, BINAL-H-mediated addition of (Z,E)-sorbamide to a macrocyclic aldehyde precursor. The synthesis of the commonfunctionalized morpholine building block involved two con-secutive epoxide openings with tosylamide and the productof the first opening reaction, respectively, as nucleophiles. Ofthe three morpholino-zampanolides investigated, the N -acetyl and the N-benzoyl derivatives both exhibited nano-molar antiproliferative activity, thus being essentially equipo-tent with the natural product. In contrast, the activity of theN-tosyl derivative was significantly reduced., We gratefully acknowledge financial support by the Swiss National Science Foundation (projects 200021_149253 and200020_175744 (KHA)), Funding was also obtained from Ministerio de Ciencia e Innovación PID2019-104545RB-I00 and Fondo de Investigaciones Sanitarias COV20/01007 (JFD) andH2020-MSCA-ITN-2019 860070 TUBINTRAIN (JFD)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Studies toward the synthesis of an oxazole-based analog of (−)-zampanolide

  • Bold, Christian Paul
  • Klaus, Cindy
  • Pfeiffer, Bernhard
  • Schürmann, Jasmine
  • Lombardi, Rafael
  • Lucena-Agell, Daniel
  • Díaz, José Fernando
  • Altmann, Karl-Heinz
5 p.-2 fig.-4 schem.-1 graph. abst., Studies are described toward the synthesis of an oxazole-based analog of (−)-zampanolide (2). Construction of (−)-dactylolide analog 22 was achieved via alcohol 5 and acid 4 through esterification and Horner–Wadsworth–Emmons (HWE)-based macrocyclization; however, attempts to attach (Z,E)-sorbamide to 22 proved unsuccessful. The C(8)–C(9) double bond of the macrocycle was prone to migration into conjugation with the oxazole ring, which may generally limit the usefulness of zampanolide analogs with aromatic moieties as tetrahydropyran replacements., We gratefully acknowledge financial support by the Swiss National Science Foundation (Projects 200021_149253 and 200020_175744 (K.H.A.)). Funding was also obtained from Ministerio de Ciencia e Innovación PID2019-104545RB-I00 and Fondo de Investigaciones Sanitarias COV20/01007 (J.F.D.) and H2020-MSCA-ITN-2019 860070 TUBINTRAIN (J.F.D.)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Maytansinol derivatives: side reactions as a chance for new tubulin binders

  • Marzullo, Paola
  • Boiarska, Zlata
  • Pérez-Peña, Helena
  • Abel, Anne-Catherine
  • Álvarez-Bernad, Beatriz
  • Lucena-Agell, Daniel
  • Vasile, Francesca
  • Sironi, Maurizio
  • Altmann, Karl-Heinz
  • Prota, Andrea E.
  • Díaz, José Fernando
  • Pieraccini, Stefano
  • Passarella, D.
11 p.-8 fig.-6 tab.-1 schem, Maytansinol is a valuable precursor for the preparation of maytansine derivatives (known as maytansinoids). Inspired by its intriguing structure and their success in targeted cancer therapy, we explored the maytansinol acylation reaction. As a result, we were able to obtain a series of derivatives, bearing novel modifications of the maytansine scaffold. We characterized these molecules by docking studies, by a comprehensive biochemical evaluation and by determination of their crystal structures in complex with tubulin. The obtained results shed further light on the intriguing chemical behavior of maytansinoids and confirm the relevance of this peculiar scaffold in the scenario of tubulin binders., This work was supported by the H2020-MSCA-ITN-2019 (860070 TUBINTRAIN),Ministerio de Ciencia e Innovación PID2019-104545RB-I00, PIE 201920E111 and PIE 202020E301 from CSIC, Fundacion Tatiana Pérez de Guzmán el Bueno. Open Access Funding provided by Universita degli Studi di Milano within the CRUI-CARE Agreement., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Design, synthesis, and in vitro evaluation of tubulin-targeting dibenzothiazines with antiproliferative activity as a novel heterocycle building block

  • Guerra, Walter D.
  • Lucena-Agell, Daniel
  • Hortigüela, Rafael
  • Rossi, Roberto A.
  • Díaz, José Fernando
  • Padrón, José M.
  • Barolo, Silvia M.
14 p.-4 fig.-2 tab.- 8 schem., We prepared a series of free NH and N-substituted dibenzonthiazines with potential anti-tumor activity from N-aryl-benzenesulfonamides. A biological test of synthesized compounds (59 samples) was performed in vitro measuring their antiproliferative activity against a panel of six human solid tumor cell lines and its tubulin inhibitory activity. We identified 6-(phenylsulfonyl)-6H-dibenzo[c,e][1,2]thiazine 5,5-dioxide and 6-tosyl-6H-dibenzo[c,e][1,2]thiazine 5,5-dioxide as the best compounds with promising values of activity (overall range of 2-5.4 μM). Herein, we report the dibenzothiazine core as a novel building block with antiproliferative activity, targeting tubulin dynamics., This study was supported by Agencia Córdoba Ciencia,Consejo Nacional de Investigaciones Científicas y Técnicas(CONICET),Secretaría de Ciencia y Tecnología,Universidad Nacional de Córdoba (SECyT),and Agencia Nacional de Promoción Científica y Técnica(ANPCyT).W. D. G. gratefully acknowledge receipt of fellowship from CONICET.J. M. P. thanks the Spanish Government for financial support through project PGC2018-094503-B-C22(MCIU/AEI/FEDER,UE). The biochemical work was supported by grants Ministerio de Ciencia e Innovación PID2019-104545RB-I00/AEI/10.13039/501100011033,PIEs 201920E111 and 202020E301 from Consejo Superior de Investigaciones Científicas,grant “Bases moleculares de la regulación de microtúbulos y sus implicaciones en la neurotoxicidad producida por fármacos ”from Fundación TATIANA and European Union H2020-MSCA-ITN-2019 860070TUBINTRAIN grant to JFDP and a generous donation from Club Deportivo Escuela Hungaresa de Pontevedra., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Lattice defects induced by microtubule-stabilizing agents exert a long-range effect on microtubule growth by promoting catastrophes

  • Rai, Ankit
  • Liu, Tianyang
  • Katrukha, Eugene A.
  • Estévez-Gallego, Juan
  • Manka, Szymon W.
  • Paterson, Ian
  • Díaz, José Fernando
  • Kapitein, Lukas C.
  • Moores, Carolyn A.
  • Akhmanova, Anna
11 p.-5 fig., icrotubules are dynamic cytoskeletal polymers that spontane ously switch between phases of growth and shrinkage. The probability of transitioning from growth to shrinkage, termed catastrophe, increases with microtubule age, but the underlying mechanisms are poorly understood. Here, we set out to test whether microtubule lattice defects formed during polymerization can affect growth at the plus end. To generate microtubules with lattice defects, we used microtubule-stabilizing agents that pro mote formation of polymers with different protofilament num bers. By employing different agents during nucleation of stable microtubule seeds and the subsequent polymerization phase, we could reproducibly induce switches in protofilament number and induce stable lattice defects. Such drug-induced defects led to fre quent catastrophes, which were not observed when microtubules were grown in the same conditions but without a protofilament number mismatch. Microtubule severing at the site of the defect was sufficient to suppress catastrophes. We conclude that struc tural defects within the microtubule lattice can exert effects that can propagate over long distances and affect the dynamic state of the microtubule end., This work was supported by European Research Council Synergy Grant 609822 and Netherlands Organization for Scientific Research (NWO) CW ECHO Grant 711.015.005 (to A.A.), Biotechnology and Biological Sciences Research Council Grant BB/N018176/1 (to C.A.M.), and grants from Fundacion TATIANA, 20202020E301 from the Spanish National Research Council, and PID2019-104545RB-I00 from Ministerio de Ciencia,Innovacion y Universidades (to J.F.D.). S.W.M. was supported by a grant from the Medical Research Council, UK (to C.A.M.) (MR/R000352/1)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Effect of Clinically Used Microtubule Targeting Drugs on Viral Infection and Transport Function

  • Oliva, María A.
  • Tosat-Bitrian, Carlota
  • Barrado-Gil, Lucía
  • Bonato, Francesca
  • Galindo Barreales, Inmaculada
  • Garaigorta, Urtzi
  • Álvarez-Bernad, Beatriz
  • París-Ogáyar, Rebeca
  • Lucena-Agell, Daniel
  • Giménez-Abián, Juan F.
  • García-Dorival, Isabel
  • Urquiza, Jesús
  • Gastaminza, Pablo
  • Díaz, José Fernando
  • Palomo, Valle
  • Alonso Martí, Covadonga
Microtubule targeting agents (MTAs) have been exploited mainly as anti-cancer drugs because of their impact on cellular division and angiogenesis. Additionally, microtubules (MTs) are key structures for intracellular transport, which is frequently hijacked during viral infection. We have analyzed the antiviral activity of clinically used MTAs in the infection of DNA and RNA viruses, including SARS-CoV-2, to find that MT destabilizer agents show a higher impact than stabilizers in the viral infections tested, and FDA-approved anti-helminthic benzimidazoles were among the most active compounds. In order to understand the reasons for the observed antiviral activity, we studied the impact of these compounds in motor proteins-mediated intracellular transport. To do so, we used labeled peptide tools, finding that clinically available MTAs impaired the movement linked to MT motors in living cells. However, their effect on viral infection lacked a clear correlation to their effect in motor-mediated transport, denoting the complex use of the cytoskeleton by viruses. Finally, we further delved into the molecular mechanism of action of Mebendazole by combining biochemical and structural studies to obtain crystallographic high-resolution information of the Mebendazole-tubulin complex, which provided insights into the mechanisms of differential toxicity between helminths and mammalians., This work was supported by Ministerio de Ciencia e Innovación PID2019-104545RBI00/ AEI/10.13039/501100011033 to JFD and RTI2018-097305-R-I00 to CA, Consejo Superior de Investigaciones Científicas PIE 201920E111 to JFD, PIE 202020E301 and the European Commission– NextGenerationEU (Regulation EU 2020/2094), through CSIC’s Global Health Platform (PTI Salud Global) to JFD and CA, H2020-MSCA-ITN-2019 860070 TUBINTRAIN to JFD, “La Caixa” Banking Foundation (LCF/PR/HR19/52160012) to CA, Postdoctoral Junior Leader Fellowship Programme from ‘La Caixa’ Banking Foundation (LCF/BQ/PR18/11640007) to VP and Ministerio de Ciencia e Innovacion FPI program (PRE2020-094384) to BAB and Ministerio de Educación FPU program (FPU18/06310) to CTB. We also acknowledge a generous donation from Club Deportivo Escuela Hungaresa de Pontevedra., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Targeting the tubulin C-terminal tail by charged small molecules

  • Li, Shuo
  • Mori, Mattia
  • Yang, Mingyan
  • Elfazazi, Soumia
  • Hortigüela, Rafael
  • Chan, Peter
  • Feng, Xinyue
  • Risinger, April L.
  • Yang, Zhiyou
  • Oliva, María A.
  • Díaz, José Fernando
  • Fang, Wei-Shuo
21 p.-6 fig.-3 schem. This paper is dedicated to the late professor Maurizio Botta, University of Siena., The disordered tubulin C-terminal tail (CTT), which possesses a higher degree of heterogeneity, is the target for the interaction of many proteins and cellular components. Compared to the seven well-described binding sites of microtubule-targeting agents (MTAs) that localize on the globular tubulin core, tubulin CTT is far less explored. Therefore, tubulin CTT can be regarded as a novel site for the development of MTAs with distinct biochemical and cell biological properties. Here, we designed and synthesized linear and cyclic peptides containing multiple arginines (RRR), which are complementary to multiple acidic residues in tubulin CTT. Some of them showed moderate induction and promotion of tubulin polymerization. The most potent macrocyclic compound 1f was found to bind to tubulin CTT and thus exert its bioactivity. Such RRR containing compounds represent a starting point for the discovery of tubulin CTT-targeting agents with therapeutic potential., This research was funded by the CAMS Innovation Fund for Medical Sciences (Grant No. 2016-I2M-1-010), State Key Lab Grant type C (Grant No. GTZC201709) (W.-S. F.), Ministerio de Ciencia e Innovación (Grant No. PID2021-123399OB-I00 /AEI/10.13039/501100011033) (M. Á. O.), Ministerio de Ciencia e Innovacion (Grant No. PID2019-104545RB-I00 /AEI/10.13039/501100011033), European Commission-NextGenerationsEU (Regulation EU 2020/2094, through CSIC's Global Health Platform (PTI Salud Global)), Proyecto de Investigación en Neurociencia Fundacion Tatiana Pérez de Guzmán el Bueno 2020 (J. F. D.), the Voelcker Fund (A. R.), the Natural Science Foundation of Guangdong Province of China (Grant No. 2022A1515011419), and the Key Project in Higher Education of Guangdong, China (Grant No. 2022ZDZX2029) (Z. Y.)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Synthesis and biological evaluation of C(13)/C(13′)-Bis(desmethyl)disorazole Z**

  • Bold, Christian Paul
  • Lucena-Agell, Daniel
  • Oliva, María A.
  • Díaz, José Fernando
  • Altmann, Karl-Heinz
9 p.-5 fig.-1 tab. 1 graph. abst., We describe the total synthesis of the macrodiolide C(13)/C(13′)-bis(desmethyl)disorazole Z through double inter-/intramolecular Stille cross-coupling of a monomeric vinyl stannane/vinyl iodide precursor to form the macrocycle. The key step in the synthesis of this precursor was a stereoselective aldol reaction of a formal Evans acetate aldol product with crotonaldehyde. As demonstrated by X-ray crystallography, the binding mode of C(13)/C(13′)-bis(desmethyl)disorazole Z to tubulin is virtually identical with that of the natural product disorazole Z. Likewise, C(13)/C(13′)-bis(desmethyl)disorazole Z inhibits tubulin assembly with at least the same potency as disorazole Z and it appears to be a more potent cell growth inhibitor., This work was supported by grants from the Ministerio de Ciencia e Innovación PID2019-104545RB-I00, Proyecto de Investigación en Neurociencia Fundacion Tatiana Pérez de Guzmán el Bueno 2020, and the European Union NextGenerationEU (J.F.D.). Institutional support by the ETH Zurich is gratefully acknowledged (K.-H.A.)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Maytansinol functionalization:towards useful probes for studying microtubule dynamics

  • Boiarska, Zlata
  • Pérez-Peña, Helena
  • Abel, Anne-Catherine
  • Marzullo, Paola
  • Álvarez-Bernad, Beatriz
  • Bonato, Francesca
  • Santini, Benedetta
  • Horvath, Dragos
  • Lucena-Agell, Daniel
  • Vasile, Francesca
  • Sironi, Maurizio
  • Díaz, José Fernando
  • Prota, Andrea E.
  • Pieraccini, Stefano
  • Passarella, D.
11 p.-7 fig.-4 tab. 7 schem., Maytansinoids are a successful class of natural and semisynthetic tubulin binders, known for their potent cytotoxic activity. Their wider application as cytotoxins and chemical probes to study tubulin dynamics has been held back by the complexity of natural product chemistry. Here we report the synthesis of long-chain derivatives and maytansinoid conjugates. We confirmed that bulky substituents do not impact their high activity or the scaffold's binding mode. These encouraging results open new avenues for the design of new maytansine-based probes., This work was supported by the H2020-MSCA-ITN-2019 (860070 TUBINTRAIN), Ministerio de Ciencia e Innovación PID2019-104545RB−I00 (JFD), Proyecto de Investigación en Neurociencia Fundación Tatiana Pérez de Guzmán el Bueno 2020, and by the European Union NextGenerationEU (J.F.D.). Open Access Funding provided by $INSTITUTION within the CRUI-CARE Agreement., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Chemical modulation of microtubule structure through the laulimalide/peloruside site

  • Estévez-Gallego, Juan
  • Álvarez-Bernad, Beatriz
  • Benet, Pera
  • Wullschleger, Christoph
  • Raes, Olivier
  • Menche, Dirk
  • Martínez, Juan Carlos
  • Lucena-Agell, Daniel
  • Prota, Andrea E.
  • Bonato, Francesca
  • Bargsten, Katja
  • Cornelus, Jelle
  • Giménez-Abián, Juan F.
  • Northcote, Peter
  • Steinmetz, Michel O.
  • Kamimura, Shinji
  • Altmann, Karl-Heinz
  • Paterson, Ian
  • Gago, Federico
  • Van der Eycken, Johan
  • Díaz, José Fernando
  • Oliva, María A.
17 p.-5 fig.1 graph. abst., Taxanes are microtubule-stabilizing agents used in the treatment of many solid tumors, but they often involve side effects affecting the peripheral nervous system. It has been proposed that this could be related to structural modifications on the filament upon drug binding. Alternatively, laulimalide and peloruside bind to a different site also inducing stabilization, but they have not been exploited in clinics. Here, we use a combination of the parental natural compounds and derived analogs to unravel the stabilization mechanism through this site. These drugs settle lateral interactions without engaging the M loop, which is part of the key and lock involved in the inter-protofilament contacts. Importantly, these drugs can modulate the angle between protofilaments, producing microtubules of different diameters. Among the compounds studied, we have found some showing low cytotoxicity and able to induce stabilization without compromising microtubule native structure. This opens the window of new applications for microtubule-stabilizing agents beyond cancer treatment., This work was supported by Ministerio de Ciencia e Innovación PID2021-123399OB-I00 and PID2019-104545RBI00 to M.O.B. and J.F.D.;/AEI/10.13039/501100011033, Consejo Superior de Investigaciones Científicas PIE 201920E111, the European Commission-NextGenerationsEU (Regulation EU 2020/2094), through CSIC’s Global Health Plat-form (PTI Salud Global), and Proyecto de Investigación en Neurociencia Fundacion Tatiana Pérez de Guzmán el Bueno 2020 to J.F.D.; H2020-MSCA-ITN-2019 860070 TUBINTRAIN to J.F.D. and A.E.P.; Swiss National Science Foundation (31003A_166608) to M.O.S.; Ministerio de Universidades fellowship FPU15/03140 to J.E.G.; European Commission IHP Networks HPRN-CT-2000-18 and HPRN-CT-2000-00014 to I.P. and postdoctoral fellowship to D.M. We thank staff of beamlines BL11-NDC-SWEET (ALBA, CELLS, Cerdanyola del Vallès, Spain), X06DA of the Swiss Light Source (Paul Scherrer Institut, Villigen PSI, Switzerland), and ID30B of the European Synchrotron Radiation Facility (ESRF, Grenoble, France) for their support. We also thank Ganadería Fernando Díaz for calf brains supply and Escuela Hongaresa de Esgrima de Pontevedra for its private donation to the project., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Structural insight into the stabilization of microtubules by taxanes

  • Prota, Andrea E.
  • Lucena-Agell, Daniel
  • Ma, Yuntao
  • Estévez-Gallego, Juan
  • Li, Shuo
  • Bargsten, Katja
  • Josa-Prado, Fernando
  • Altmann, Karl-Heinz
  • Gaillard, Natacha
  • Kamimura, Shinji
  • Mühlethaler, Tobias
  • Gago, Federico
  • Oliva, María A.
  • Steinmetz, Michel O.
  • Fang, Wei-Shuo
  • Díaz, José Fernando
35 p.-12 fig.-2 tab.-3 animat.-1 schem.This article is dedicated to the memory of Dr Linda Amos, a dear friend and pioneer in the study of microtubules and the mechanism of action of paclitaxel (Amos and Löwe, 1999), who passed away while we were assembling this manuscript., Paclitaxel (Taxol) is a taxane and a chemotherapeutic drug that stabilizes microtubules. While the interaction of paclitaxel with microtubules is well described, the lack of high-resolution structural information on a tubulin-taxane complex precludes a comprehensive description of the binding determinants that affect its mechanism of action. Here, we solved the crystal structure of baccatin III the core moiety of paclitaxel-tubulin complex at 1.9 Å resolution. Based on this information, we engineered taxanes with modified C13 side chains, solved their crystal structures in complex with tubulin, and analyzed their effects on microtubules (X-ray fiber diffraction), along with those of paclitaxel, docetaxel, and baccatin III. Further comparison of high-resolution structures and microtubules’ diffractions with the apo forms and molecular dynamics approaches allowed us to understand the consequences of taxane binding to tubulin in solution and under assembled conditions. The results sheds light on three main mechanistic questions: (1) taxanes bind better to microtubules than to tubulin because tubulin assembly is linked to a βM-loopconformational reorganization (otherwise occludes the access to the taxane site) and, bulky C13 side chains preferentially recognize the assembled conformational state; (2) the occupancy of the taxane site has no influence on the straightness of tubulin protofilaments and; (3) longitudinal expansion of the microtubule lattices arises from the accommodation of the taxane core within the site, a process that is no related to the microtubule stabilization (baccatin III is biochemically inactive). In conclusion, our combined experimental and computational approach allowed us to describe the tubulin-taxane interaction in atomic detail and assess the structural determinants for binding., Ministerio de Ciencia e Innovación (PID2019-104545RB-I00 (AEI/10.13039/501100011033)) J Fernando Díaz Consejo Superior de Investigaciones Científicas (PIE 201920E111) J Fernando Díaz Fundación Tatiana Pérez de Guzmán el Bueno (Proyecto de Investigación en Neurociencia 2020) J Fernando Díaz European Union NextGenerationEU (H2020-MSCA-ITN-2019 860070 TUBINTRAIN) Andrea E Prota J Fernando Díaz Swiss National Science Foundation (310030_192566) Michel O Steinmetz JSPS KAKENHI (16K07328/17H03668) Shinji Kamimura National Natural Science Foundation of China (30930108) Wei-Shuo Fang Chinese Academy of Medical Sciences (2016-I2M-1-010) Wei-Shuo Fang Ministerio de Ciencia e Innovación (PID2019-104070RB-C22 (AEI/10.13039/501100011033)) Federico Gago We thank Ganadería Fernando Díaz for calf brains supply and staff of beamlines X06DA of the Swiss Light Source (Paul Scherrer Institut, Villigen PSI, Switzerland) and BL11-NDC-SWEET (ALBA, Cerdanyola del Vallès, Spain) for their support. We also thank Mr Pedro Gascón Blanco for his private donation to the project to support a month of a student salary., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Synthesis and structure-activity relationship studies of C(13)-desmethylene-(−)-zampanolide analogs

  • Brütsch, Tobias M.
  • Cotter, Etienne
  • Lucena-Agell, Daniel
  • Redondo-Horcajo, Mariano
  • Davies, Carolina
  • Pfeiffer, Bernhard
  • Pagani, Sandro
  • Berardozzi, Simone
  • Díaz, José Fernando
  • Miller, John H.
  • Altmann, Karl-Heinz
14 p.-4 fig.-2 tab., We describe the synthesis and biochemical and cellular profiling of five partially reduced or demethylated analogs of the marine macrolide (−)-zampanolide (ZMP). These analogs were derived from 13-desmethylene-(−)-zampanolide (DM-ZMP), which is an equally potent cancer cell growth inhibitor as ZMP. Key steps in the synthesis of all compounds were the formation of the dioxabicyclo[15.3.1]heneicosane core by an intramolecular HWE reaction (67–95 % yield) and a stereoselective aza-aldol reaction with an (S)-BINOL-derived sorbamide transfer complex, to establish the C(20) stereocenter (24–71 % yield). As the sole exception, for the 5-desmethyl macrocycle, ring-closure relied on macrolactonization; however, elaboration of the macrocyclization product into the corresponding zampanolide analog was unsuccessful. All modifications led to reduced cellular activity and lowered microtubule-binding affinity compared to DM-ZMP, albeit to a different extent. For compounds incorporating the reactive enone moiety of ZMP, IC50 values for cancer cell growth inhibition varied between 5 and 133 nM, compared to 1–12 nM for DM-ZMP. Reduction of the enone double bond led to a several hundred-fold loss in growth inhibition. The cellular potency of 2,3-dihydro-13-desmethylene zampanolide, as the most potent analog identified, remained within a ninefold range of that of DM-ZMP., This workwas supported by the Swiss National Science Foundation (KHA,project200021_149253). Institutional support by the ETH Zurich is also gratefully acknowledged(KHA).Funding was also received from Ministerio de Ciencia e Innovación(Spain) (JFD,Project PID2019-104545RB-I00/AEI/10.13039/501100011033),the European Commission-NextGenerations EU(RegulationEU 2020/2094),through CSIC’s Global Health Platform(PTI Salud Global) and Proyecto de Investigación en Neurociencia Fundación Tatiana Pérez de Guzmán el Bueno 2020 (JFD)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Modulation of taxane binding to tubulin curved and straight conformations by systematic 3′N modification provides for improved microtubule binding, persistent cytotoxicity and in vivo potency

  • Ma, Yuntao
  • Josa-Prado, Fernando
  • Essif, Jacob Nathaniel
  • Liu, Shuqi
  • Li, Shuo
  • Lucena-Agell, Daniel
  • Chan, Peter
  • Goossens, Kenneth
  • Hortigüela, Rafael
  • Matesanz, Ruth
  • Wang, Yingjie
  • Gago, Federico
  • Wang, Hongbo
  • Risinger, April L.
  • Díaz, José Fernando
  • Fang, Wei-Shuo
28p.-6 fig.-4 tab.-1 schem., The taxane class of microtubule stabilizers are some of the most effective and widely used chemotherapeutics. The anticancer activity of taxanes arises from their ability to induce tubulin assembly by selectively recognizing the curved (c-) conformation in unassembled tubulin as compared to the straight (s-) conformation in assembled tubulin. We first designed and synthesized a series of 3′N-modified taxanes bearing covalent groups. Instead of discovering covalent taxanes, we found a series of non-covalent taxanes 2, in which the 3′N side chain was found to be essential for cytotoxicity due to its role in locking tubulin in the s-conformation. A representative compound bearing an acrylamide moiety (2h) exhibited increased binding affinity to the unassembled tubulin c-conformation and less cytotoxicity than paclitaxel. Further exploration of chemical space around 2h afforded a new series 3, in which derivatives such as 3l bind more tightly to both the s- and c-conformations of tubulin compared to paclitaxel, leading to more efficient promotion of tubulin polymerization and a greater persistence of in vitro efficacy against breast cancer cells after drug washout. Although 3l also had improved in vivo potency as compared to paclitaxel, it was also associated with increased systemic toxicity that required localized, intratumoral injection to observe potent and prolonged antitumor efficacy., Financial support from CIFMS (Grant No. 2016-I2M-1-010), State Key Lab Grant type C (No. GTZC201709), NSFC (Grant No. 30930108), NSFC (Grant No. 82073888), the Science and Technology Support Program for Youth Innovation in Universities of Shandong (Grant No. 2019KJM009), the Spanish Ministerio de Ciencia e Innovación PID2019-104545RB-I00 (AEI/10.13039/501100011033) and PID2019-104070RB-C22 (AEI/ 10.13039/501100011033), Proyecto de Investigación en Neurociencia Fundación Tatiana Pérez de Guzmán el Bueno 2020, and by the European Union Next Generation EU and the Voelcker Fund are gratefully acknowledged. Flow cytometry data was generated in the Flow Cytometry Shared Resource Facility, which is supported by UT Health, NIH-NCI P30 CA054174-20 (CTRC at UT Health) and UL1 TR001120 (CTSA grant)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Tesis doctoral (DoctoralThesis)

Diferencias en la cinética y consecuencias de la evasión del punto de chequeo del huso: líneas celulares humanas versus de roedores

  • Álvarez Bernad, Beatriz
Tesis inédita de la Universidad Complutense de Madrid, Facultad de Farmacia, leída el 17/12/2025. Esta tesis tiene embargo hasta el 17/12/2026, [EN] The cell cycle is an organized series of events that lead to the formation of two daughter cells from a mother cell. The cell cycle must be strictly regulated to ensure the correct progression of the cell, thus there are checkpoints that secure that a process does not begin if the previous one has not been successfully completed. One of the main checkpoints in the cell cycle is the spindle assembly checkpoint (SAC), which controls the metaphase-anaphase transition during cell division. The SAC remains active from the onset of mitosis, when kinetochores which are not attached to spindle microtubules inhibit the activation of the anaphase-promoting complex or cyclosome (APC/C). Once all the kinetochores of the chromosomes have bioriented on the equatorial plate, the checkpoint is satisfied, the APC/C is activated and the cohesion between sister chromatids is lost and cyclin B is degraded, licensing the anaphase. When cells are treated with antimitotic drugs, they are blocked in mitosis and can follow different fates 1) to die in mitosis or 2) to evade the SAC, a process that is called mitotic slippage. The mechanisms that allow cells to escape from a prolonged block in mitosis are currently unknown. After mitotic slippage, cells with nuclear aberrations are generated, mainly with micronuclei or restitution nuclei. These cells can undergo different fates: death, arrest in G1 or a second mitosis. Nowadays, the underlying success of treatments with antimitotic drugs in tumors with low proliferation rates is unclear. Regarding this proliferation rate paradox two explanations have been proposed: it is argued that micronuclei have a more labile nuclear envelope that collapses, triggering a signaling cascade that culminates with the activation of the immune system producing a bystander effect around the leading cell. Alternatively, it has been proposed that the success of these drugs is due to the generation of multipolar mitoses that produce incorrect chromosome segregation, generating such severe aneuploidies that they cause cell death. Cancer treatment with chemotherapy consists on the administration of antineoplasic drugs that affect the features of tumor cells. These drugs can be classified as aneugenics, which cause aneuploidy, or clastogenics, which affect DNA by different mechanisms. In this thesis, mitotic slippage is analyzed at the cytological level, being the main to study the differences in the kinetics of the mitotic slippage, the generation of multinucleated cells, and the dynamics of micronuclei, as well as the consequences such evasion; between human and rodent cell lines. To this end, cell lines of four species and three aneugenic compounds were used, two of which affect tubulin dynamics (paclitaxel and maytansine) and one that affects chromosome congression (GSK923295). The results obtained show that, with all the treatments, rodent cell lines do mitotic slippage faster than human cell lines. Regarding the compounds targeting tubulin, human, hamster and rat cell lines generate a higher percentage of micronucleated cells than mouse cell lines which generate restitution nuclei. In contrast, the drug that affects chromosome congression, which has no known effect on the microtubule cytoskeleton, generates cells with restitution nuclei in all cell lines. Rodent cell lines present a survival rate higher than human cell lines; as they also survive better after mitotic slippage, including a higher capacity to undergo and complete a second cell cycle. These findings suggest that there are clear differences in the response to antimitotic drugs between human and rodent lines, especially in the kinetics of the mitotic slippage. This observation may explain some of the discrepancies between in vitro, in vivo, and preclinical experimentation for drug approval, given that rodents, particularly mice, are the main in vivo research model. A second objective has been to evaluate whether the generation of nuclear aberrations is the common denominator among a battery of aneugenic and clastogenic compounds. Clastogenic drugs mainly cause DNA breaks, generating chromosomal fragments, and present a higher percentage of cells with restitution nuclei and a hybrid phenotype with very small micronuclei. In contrast, aneugenic compounds affect the machinery of mitosis by preventing the formation of an equatorial plate, causing chromosome missegregation, thus resulting in micronucleated cells, except for two compounds that behave more similarly to the clastogenic compounds. The results obtained indicate that both types of drugs generate nuclear aberrations, although the nature and origin of these abnormalities depend on the type of compound., [ES] El ciclo celular es un conjunto ordenado de eventos que conducen a la formación de dos células hijas a partir de una célula madre. Dicho ciclo debe estar estrictamente regulado para garantizar la correcta progresión del mismo, por ello, existen puntos de control que se aseguran que un proceso no comience si la finalización del anterior no se ha completado con éxito. Uno de los principales puntos de chequeo del ciclo celular es el punto de chequeo del huso (Spindle Assembly Checkpoint, SAC) que actúa en la mitosis controlando la transición metafase-anafase. El SAC permanece activo desde el inicio de la mitosis, momento en el cual los cinetocoros no anclados a microtúbulos (MTs) del huso inhiben la activación del complejo promotor de la anafase o ciclosoma (APC/C). Cuando todos los cinetocoros de los cromosomas han biorientado en la placa ecuatorial, el punto de chequeo se satisface, de tal forma que el APC/C se activa, y por un lado se pierde la cohesión entre cromátidas hermanas y, por otro, se degrada ciclina B licenciando la anafase. Al tratar las células con fármacos antimitóticos, el SAC no se satisface y permanece activo por lo que las células quedan bloqueadas en c-mitosis y pueden seguir diferentes destinos: 1) morir en mitosis o 2) evadir el SAC. Los mecanismos por los cuales las células escapan del bloqueo prolongado en mitosis no están claros en la actualidad. Al evadir el SAC, se generan células con aberraciones nucleares, como micronúcleos o núcleos de restitución. A su vez, estas células que evaden el SAC pueden sufrir diferentes destinos: muerte, arresto en G1 o volver a realizar una segunda mitosis. Hoy en día, el éxito subyacente al tratamiento con fármacos antimitóticos en tumores cuya tasa de proliferación es baja no está claro. Para resolver esta paradoja de la tasa de proliferación, se propone, por un lado, que los micronúcleos tienen una envoltura nuclear más lábil que colapsa desencadenando una cascada de señalización que culmina con la activación del sistema inmune lo cual afectaría también a las células vecinas. Alternativamente, se propone que el éxito de estos fármacos antimitóticos es debido a la generación de células multipolares que provocan una mala segregación de los cromosomas generando aneuploidías tan graves que llevan a la muerte de la célula. El tratamiento del cáncer mediante quimioterapia consiste en la administración de fármacos antineoplásicos que afectan a las características de las células tumorales. Estos fármacos pueden clasificarse como aneugénicos, que provocan aneuploidías, y clastogénicos, que afectan al ADN mediante distintos mecanismos En el presente trabajo, se analiza a nivel citológico la evasión del SAC, siendo el objetivo principal estudiar las diferencias en la cinética de evasión del punto de chequeo del huso, en la generación de células multinucleadas y en las consecuencias de dicha evasión; entre líneas celulares humanas versus de roedores. Para ello se han empleado líneas celulares de cuatro especies y tres compuestos aneugénicos, dos que afectan a la dinámica de tubulina (paclitaxel y maytansina), y un compuesto que afecta a la congresión cromosómica (GSK923295). Los resultados obtenidos muestran que, con cualquiera de los tres tratamientos, las líneas celulares de roedores evaden el punto de chequeo más rápido que las líneas humanas. Con los compuestos dirigidos contra tubulina, las líneas celulares humanas, de hámster y de rata, generan un mayor porcentaje de células micronucleadas que las de ratón que tienden a generar núcleos de restitución. Las líneas celulares humanas mueren más que las de roedores en el bloqueo c-mitótico, las que lo evaden vuelven a morir más que las de roedores al entrar en un nuevo ciclo, y las que sobreviven no son capaces de completar con éxito un segundo ciclo, al contrario que las de roedores que, en cada paso, muestran una supervivencia notablemente superior. Estos resultados sugieren que hay diferencias claras en el tratamiento con fármacos antimitóticos entre líneas humanas y de roedores, sobre todo en la cinética de evasión del SAC. Esta observación puede estar relacionada con las discrepancias entre la experimentación in vitro, in vivo y preclínica de fármacos antimitóticos, puesto que los roedores, principalmente ratones, son el principal modelo de investigación in vivo. Un segundo objetivo ha consistido en evaluar si la generación de aberraciones nucleares es el denominador común entre una batería de compuestos aneugénicos y clastogénicos. Los fármacos clastogénicos principalmente provocan roturas en el ADN, generando fragmentos cromosómicos, de tal forma que presentan un mayor porcentaje de células con núcleos de restitución y un fenotipo híbrido con micronúcleos de muy pequeño tamaño. Por el contrario, los aneugénicos afectan a la maquinaria de la mitosis impidiendo la formación de una placa ecuatorial de tal forma que causan una incorrecta segregación de los cromosomas originando células micronucleadas, a excepción de dos compuestos que tienen un comportamiento más similar a los clastogénicos. Los resultados obtenidos indican que ambos tipos de compuestos coinciden en generar aberraciones nucleares pero su origen y el tipo de aberración depende del tipo de compuesto, Este trabajo ha sido financiado a través de los proyectos: ID2022-136765OB-I00 y PID2019-104545RB- I00 del Ministerio de Ciencia e Innovacion. SGL2103051 de los Fondos de Recuperación Europeos y el proyecto, Bases moleculares de la regulación de microtúbulos y sus implicaciones en la neurotoxicidad producida por fármacos de la Fundación TATIANA. La doctoranda recibidó una beca FPI (PRE2020-094384) incluida en el proyecto PID2019-104545RB- I00, Peer reviewed, Modelo experimental alternativo-NAM, in vitro - Tipos celulares - líneas inmortalizadas humanas, in vitro - Tipos celulares - líneas inmortalizadas animales no humanas
Docta Complutense
Publication Artículo científico (JournalArticle)

Structural basis of noscapine activation for tubulin binding

  • Canales Mayordomo, María Ángeles
  • Bargsten, Katja
  • Bennani, Youssef L.
  • Díaz, Fernando J.
  • Jiménez Barbero, Jesús
  • Oliva, María A.
  • Prota, Andrea E.
  • Rodríguez Salarichs, J.
  • Steinmetz, Michel O.
Noscapine is a natural alkaloid that is used as an antitussive medicine. However, it also acts as a weak anticancer agent in certain in vivo models through a mechanism that is largely unknown. Here, we performed structural studies and show that the cytotoxic agent 7A-O-demethoxy-amino-noscapine (7A-aminonoscapine) binds to the colchicine site of tubulin. We suggest that the 7A-methoxy group of noscapine prevents binding to tubulin due to a steric clash of the compound with the T5-loop of α-tubulin. We further propose that the anticancer activity of noscapine arises from a bioactive metabolite that binds to the colchicine site of tubulin to induce mitotic arrest through a microtubule cytoskeleton-based mechanism.